Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease

2 Sept 2017

Abstract excerpt

Hematopoietic cell transplantation (HCT) using an HLA-identical sibling donor offers a very high likelihood of cure with good outcomes for patients with sickle cell disease (SCD), and alternative donor HCT for SCD is an area of active clinical research. Thus, HCT is a potential option for a growing number of patients with SCD. This expanded use of HCT has raised several ethical questions. Who is eligible for HCT,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Hemoglobinopathies and Related Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28870775
DOI: 10.1016/j.bbmt.2017.08.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell DiseasePMID 28870775Read ↗

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges facedSemantic proximity Read ↗

Update of hematopoietic cell transplantation for sickle cell diseaseSemantic proximity Read ↗

Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerationsSemantic proximity Read ↗

How I treat sickle cell disease with hematopoietic cell transplantationSemantic proximity Read ↗

Hematopoietic Cell Transplantation for Sickle Cell DiseaseSemantic proximity Read ↗

Children as Hematopoietic Stem Cell DonorsSemantic proximity Read ↗

In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune SystemSemantic proximity Read ↗

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell diseaseSemantic proximity Read ↗

Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell diseaseSemantic proximity Read ↗

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell diseaseSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell DiseaseSemantic proximity Read ↗

When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.